Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic modulation of brain perfusion and metabolism in multiple sclerosis
NL-OMON29781Phase 2Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cisapride and clenbuterol in multiple sclerosis (MS) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Change in cerebral perfusion and Change in cerebral metabolism. Started Nov 2007; status: recruiting.
02
Drugs
cisaprideclenbuterol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON29781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29781.